Select Publications

The Early Breast Cancer Trialists ’Collaborative Group Web link

Collins R,Gray R,Godwin J,Peto R.Avoidance of large biases and large random errors in the assessment of moderate treatment effects:The need for systematic overviews. Stat Med 1987;6:245-250. Abstract

Early Breast Cancer Trialists ’Collaborative Group. Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer: An overview of 61 randomized trials among 28,896 women. N Engl J Med 1988;319:1681-1691. Abstract

Early Breast Cancer Trialists ’Collaborative Group. Effects of radiotherapy and surgery in early breast cancer:An overview of the randomized trials. N Engl J Med 1995;333:1444-1455.Abstract

Early Breast Cancer Trialists ’Collaborative Group. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer:An overview of the randomised trials. Lancet 2000;355(9217):1757-70.Abstract

Early Breast Cancer Trialists ’Collaborative Group.Ovarian ablation in early breast cancer:Overview of the randomised trials. Lancet 1996;348:1189-1196. Abstract

Early Breast Cancer Trialists ’Collaborative Group. Polychemotherapy for early breast cancer:An overview of the randomised trials. Lancet 1998;352:930-942. Abstract

Early Breast Cancer Trialists ’Collaborative Group.Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy:133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet 1992;339:1-15 &71-85. Abstract

Early Breast Cancer Trialists ’Collaborative Group.Tamoxifen for early breast
cancer: An overview of the randomised trials. Lancet 1998;351:1451-1467. Abstract

Early Breast Cancer Trialists ’Collaborative Group.Treatment of early breast cancer.Vol.I:Worldwide evidence 1985-1990. Oxford University Press 1990. No Abstract Avbailable.

CLINICAL TRIALS

Adams J et al. Recruiting older adults for clinical trials. Control Clin Trials 1997;18(1):14-26. Abstract

Albrecht TL et al. Strategic physician communication and oncology clinical trials. J Clin Oncol 1999;17:3324-3332. Abstract

Antman KH. Randomized trials of high-dose chemotherapy for breast cancer. Biochem Biophys Acta 2001;1471(3):M89-98. Abstract

Baum M,Houghton J. Contribution of randomised controlled trials to understanding and management of early breast cancer. Br Med J 1999;319:568-571. Abstract

Belanger D et al. How American oncologists treat breast cancer:An assessment of the influence of clinical trials. J Clin Oncol 1991;9:7-16. Abstract

Chirikos TN et al. Impact of clinical trials on the cost of cancer care. Med Care 2001;39(4):373-83. Abstract

Cox K. Enhancing cancer clinical trial management:Recommendations from a qualitative study of trial participants ’experiences. Psychooncology 2000;9(4):314-22. Abstract

Daugherty CK. Impact of therapeutic research on informed consent and the ethics of clinical trials:A medical oncology perspective. J Clin Oncol 1999;17(5):1601-17. Abstract

Ellis PM. Attitudes towards and participation in randomised clinical trials in oncology:A review of the literature. Ann Oncol 2000;11(8):939-45. Abstract

Ellis PM et al.Randomized clinical trials in oncology:Understanding and attitudes predict willingness to participate. J Clin Oncol 2001;19:3554-3561. Abstract

Fallowfield L et al. Clinicians’attitudes to clinical trials of cancer therapy. Eur J Cancer 1997;33(13):2221-2229. Abstract

Fireman BH et al. Cost of care for patients in cancer clinical trials. J Natl Cancer Inst 2000;92:136-142. Abstract

Fleissig A et al. Results of an intervention study to improve communication about randomised clinical trials of cancer therapy. Eur J Cancer 2001;37(3):322-31. Abstract

Giuliano AR et al. Participation of minorities in cancer research: The influence of structural, cultural and linguistic factors. Ann Epidemiol 2000;10(8 Suppl):S22-34.Abstract

Grant CH 3rd et al. Patients ’perceptions of physicians,communication and
outcomes of the accrual to trial process. Health Commun 2000;12(1):23-39.
Abstract

Hutchins LF et al. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med 1999;341:2061-7. Abstract

Kemeny M et al. Barriers to participation of older women with breast cancer in clinical trials. Proc ASCO 2000; Abstract 2371.

Lara PN et al. Prospective evaluation of cancer clinical trial accrual patterns:Identifying potential barriers to enrollment. J Clin Oncol 2001;19:1728-1733. Abstract

Ling J et al. What influences participation in clinical trials in palliative care in a cancer centre? Eur J Cancer 2000;36(5):621-6. Abstract

Pinto HA et al. Physician perspectives on increasing minorities in cancer clinical trials:An Eastern Cooperative Oncology Group (ECOG)Initiative. Ann Epidemiol 2000;10(8 Suppl):S78-84. Abstract

Ruffin MT 4th,Baron J.Recruiting subjects in cancer prevention and control studies.J Cell Biochem Suppl 2000;34:80-3. Abstract

Siminoff LA et al. Factors that predict the referral of breast cancer patients onto clinical trials by their surgeons and medical oncologists. J Clin Oncol 2000;18:1203-1211. Abstract

Sutherland HJ et al. What attitudes and beliefs underlie patients ’decisions about participating in chemotherapy trials? Med Decis Making 1998;18(1):61-69. Abstract

Trauth JM et al. Public attitudes regarding willingness to participate in medical research studies. J Health Soc Policy 2000;12(2):23-43. Abstract

Wagner JL et al. Incremental costs of enrolling cancer patients in clinical trials: A population-based study. J Natl Cancer Inst 1999;91(10):847-53. Abstract

OTHER RESOURCES

NCI Cancer Trials Support Unit (CTSU):Support for physicians and patients to participate in NCI-sponsored phase III cancer treatment trials Web link

NCI CancerNet:Search for Clinical Trials (PDQ ®) Web link

Early Breast Cancer Trialists ’Collaborative Group (EBCTCG) Web link

Return

Home · Search